Rivarola H W, Paglini-Oliva P A
Cátedra de Física Biomédica, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Santa Rosa 1085, 5000 Córdoba, Argentina.
Curr Drug Targets Cardiovasc Haematol Disord. 2002 Jun;2(1):43-52. doi: 10.2174/1568006023337745.
Chagas' disease affects about 18 million people and 25% of the population of Latin America is at risk of acquiring Chagas' disease. The chemotherapy of Chagas' disease is still an open field and remains as an unsolved problem. Nifurtimox and benznidazole are currently used to treat this disease, however, both drugs have high toxicity and are mutagenic with the result that the patients frequently fail to follow treatment. T. cruzi enzimes such as trypanothione reductase, represent potential drug targets because they play an essential role in the life of this organism. This enzyme has been isolated, purified and studied by X ray crystallography. Phenothiazines and related compounds inhibit trypanothione reductase and a specially favoured fit is a phenothiazine with a 2- substitued with 2- chloro and 2- trifluoromethyl with a remote hydrophobic patch. The essential phenothiazine nucleus can adopt more than one inhibitory orientation in its binding site. Phenothiazines and related compounds are drugs used in psychiatric treatments. These anti-depressants inhibit trypanothione reductase through the peroxidase/ H2O2/ system, and also exert other trypanocidal effects upon epimastigotes and tripomastigotes forms: clomipramine through an anticalmodulin action; trifluopherazine and thioridazine induced disruption of mitochondria and prometazine provoked serious cell membrane disorganization. Clomipramine and thioridazine were also effective in treatment of mice with experimental Chagas' disease, significantly modifying the natural evolution of the infection; cardiac function and survival of infected and treated animals were not different from non infected animals. Phenothiazines and related compounds are promising trypanocidal agents for treatment of Chagas' disease. Other trypanocidal agents as nifurtimox, benznidazol,Allopurinol, cystein protease inhibitors and others, are also discussed.
恰加斯病影响着约1800万人,拉丁美洲25%的人口有感染恰加斯病的风险。恰加斯病的化疗仍是一个有待开拓的领域,仍是一个未解决的问题。硝呋莫司和苯并硝唑目前用于治疗这种疾病,然而,这两种药物都具有高毒性且有诱变作用,结果患者经常无法坚持治疗。克氏锥虫的酶如锥虫硫醇还原酶是潜在的药物靶点,因为它们在这种生物体的生命中起着至关重要的作用。这种酶已被分离、纯化并通过X射线晶体学进行了研究。吩噻嗪及相关化合物可抑制锥虫硫醇还原酶,特别合适的结构是在2位被氯和三氟甲基取代且带有一个远程疏水基团的吩噻嗪。关键的吩噻嗪核在其结合位点可采取不止一种抑制性取向。吩噻嗪及相关化合物是用于精神治疗的药物。这些抗抑郁药通过过氧化物酶/H2O2/系统抑制锥虫硫醇还原酶,并且对前鞭毛体和无鞭毛体形式还发挥其他杀锥虫作用:氯米帕明通过抗钙调蛋白作用;三氟拉嗪和硫利达嗪诱导线粒体破坏,丙嗪引起严重的细胞膜紊乱。氯米帕明和硫利达嗪在治疗实验性恰加斯病小鼠方面也有效,显著改变了感染的自然进程;感染并接受治疗的动物的心脏功能和存活率与未感染动物无异。吩噻嗪及相关化合物是治疗恰加斯病有前景的杀锥虫剂。还讨论了其他杀锥虫剂,如硝呋莫司、苯并硝唑、别嘌呤醇、半胱氨酸蛋白酶抑制剂等。